TY - JOUR
T1 - Modulation of keratocyte phenotype by collagen fibril nanoarchitecture in membranes for corneal repair
AU - Guo, Qiongyu
AU - Phillip, Jude M.
AU - Majumdar, Shoumyo
AU - Wu, Pei Hsun
AU - Chen, Jiansu
AU - Calderón-Colón, Xiomara
AU - Schein, Oliver
AU - Smith, Barbara J.
AU - Trexler, Morgana M.
AU - Wirtz, Denis
AU - Elisseeff, Jennifer H.
N1 - Funding Information:
We acknowledge the Congressionally Directed Medical Research Program under the U.S. Army Medical Research and Materiel Command (Contract No. W81XWH-09-2-0173, Program Manager Dr. Charmaine Richman), Arthritis Foundation Postdoctoral Fellowship (QG), the Jules Stein Professorship from Research to Prevent Blindness (RPB) Foundation, and the NIH ( CA143868 and CA85839 ). We thank Vince Beachley for his critical review of the manuscript.
PY - 2013/12
Y1 - 2013/12
N2 - Type I collagen membranes with tailored fibril nanoarchitectures were fabricated through a vitrification processing, which mimicked, to a degree, the collagen maturation process of corneal stromal extracellular matrix invivo. Vitrification was performed at a controlled temperature of either 5°C or 39°C at a constant relative humidity of 40% for various time periods from 0.5wk up to 8wk. During vitrification, the vitrified collagen membranes (collagen vitrigels, CVs) exhibited a rapid growth in fibrillar density through the evaporation of water and an increase in fibrillar stiffness due to the formation of new and/or more-stable interactions. On the other hand, the collagen fibrils in CVs maintained their D-periodicity and showed no significant difference in fibrillar diameter, indicating preservation of the native states of the collagen fibrils during vitrification. Keratocyte phenotype was maintained on CVs to varying degrees that were strongly influenced by the collagen fibril nanoarchitectures. Specifically, the vitrification time of CVs mainly governed the keratocyte morphology, showing significant increases in the cell protrusion number, protrusion length, and cell size along with CV vitrification time. The CV vitrification temperature affected the regulation of keratocyte fibroblasts' gene expressions, including keratocan and aldehyde dehydrogenase (ALDH), demonstrating a unique way to control the expression of specific genes invitro.
AB - Type I collagen membranes with tailored fibril nanoarchitectures were fabricated through a vitrification processing, which mimicked, to a degree, the collagen maturation process of corneal stromal extracellular matrix invivo. Vitrification was performed at a controlled temperature of either 5°C or 39°C at a constant relative humidity of 40% for various time periods from 0.5wk up to 8wk. During vitrification, the vitrified collagen membranes (collagen vitrigels, CVs) exhibited a rapid growth in fibrillar density through the evaporation of water and an increase in fibrillar stiffness due to the formation of new and/or more-stable interactions. On the other hand, the collagen fibrils in CVs maintained their D-periodicity and showed no significant difference in fibrillar diameter, indicating preservation of the native states of the collagen fibrils during vitrification. Keratocyte phenotype was maintained on CVs to varying degrees that were strongly influenced by the collagen fibril nanoarchitectures. Specifically, the vitrification time of CVs mainly governed the keratocyte morphology, showing significant increases in the cell protrusion number, protrusion length, and cell size along with CV vitrification time. The CV vitrification temperature affected the regulation of keratocyte fibroblasts' gene expressions, including keratocan and aldehyde dehydrogenase (ALDH), demonstrating a unique way to control the expression of specific genes invitro.
KW - Collagen maturation
KW - Corneal repair
KW - Fibril nanoarchitecture
KW - Keratocyte phenotype
UR - http://www.scopus.com/inward/record.url?scp=84884819950&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84884819950&partnerID=8YFLogxK
U2 - 10.1016/j.biomaterials.2013.08.061
DO - 10.1016/j.biomaterials.2013.08.061
M3 - Article
C2 - 24041426
AN - SCOPUS:84884819950
SN - 0142-9612
VL - 34
SP - 9365
EP - 9372
JO - Biomaterials
JF - Biomaterials
IS - 37
ER -